Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of 3,9-diazabicyclo[4.2.1]nonanes as potent dual orexin receptor antagonists with sleep-promoting activity in the rat
Paul J. Coleman, John D. Schreier, Anthony J. Roecker, et al.
Bioorganic & Medicinal Chemistry Letters (2010) Vol. 20, Iss. 14, pp. 4201-4205
Closed Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Discovery of the Dual Orexin Receptor Antagonist [(7R)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the Treatment of Insomnia
Christopher D. Cox, Michael J. Breslin, David B. Whitman, et al.
Journal of Medicinal Chemistry (2010) Vol. 53, Iss. 14, pp. 5320-5332
Closed Access | Times Cited: 348
Multiple roles for orexin/hypocretin in addiction
Stephen V. Mahler, Rachel J. Smith, David E. Moorman, et al.
Progress in brain research (2012), pp. 79-121
Open Access | Times Cited: 211
Pharmacological characterization of MK-6096 – A dual orexin receptor antagonist for insomnia
Christopher J. Winrow, Anthony L. Gotter, Christopher D. Cox, et al.
Neuropharmacology (2011) Vol. 62, Iss. 2, pp. 978-987
Closed Access | Times Cited: 121
Dual Hypocretin Receptor Antagonism Is More Effective for Sleep Promotion than Antagonism of Either Receptor Alone
Stephen R. Morairty, Florent G. Revel, Pari Malherbe, et al.
PLoS ONE (2012) Vol. 7, Iss. 7, pp. e39131-e39131
Open Access | Times Cited: 117
Discovery of [(2R,5R)‐5‐{[(5‐Fluoropyridin‐2‐yl)oxy]methyl}‐2‐methylpiperidin‐1‐yl][5‐methyl‐2‐(pyrimidin‐2‐yl)phenyl]methanone (MK‐6096): A Dual Orexin Receptor Antagonist with Potent Sleep‐Promoting Properties
Paul J. Coleman, John D. Schreier, Christopher D. Cox, et al.
ChemMedChem (2012) Vol. 7, Iss. 3, pp. 415-424
Closed Access | Times Cited: 115
Orexin Receptor Antagonists: New Therapeutic Agents for the Treatment of Insomnia
Anthony J. Roecker, Christopher D. Cox, Paul J. Coleman
Journal of Medicinal Chemistry (2015) Vol. 59, Iss. 2, pp. 504-530
Closed Access | Times Cited: 107
Orexin in sleep, addiction and more: Is the perfect insomnia drug at hand?
Daniël Hoyer, Laura H. Jacobson
Neuropeptides (2013) Vol. 47, Iss. 6, pp. 477-488
Closed Access | Times Cited: 107
Orexin Receptor Antagonists as Emerging Treatments for Psychiatric Disorders
Ying Han, Kai Yuan, Yongbo Zheng, et al.
Neuroscience Bulletin (2019) Vol. 36, Iss. 4, pp. 432-448
Open Access | Times Cited: 77
Identification of a Novel Series of Orexin Receptor Antagonists with a Distinct Effect on Sleep Architecture for the Treatment of Insomnia
Claudia Betschart, Samuel Hintermann, Dirk Behnke, et al.
Journal of Medicinal Chemistry (2013) Vol. 56, Iss. 19, pp. 7590-7607
Closed Access | Times Cited: 98
Selective orexin receptor antagonists
Terry P. Lebold, Pascal Bonaventure, Brock T. Shireman
Bioorganic & Medicinal Chemistry Letters (2013) Vol. 23, Iss. 17, pp. 4761-4769
Closed Access | Times Cited: 73
Therapeutics development for addiction: Orexin-1 receptor antagonists
David A. Perrey, Yanan Zhang
Brain Research (2018) Vol. 1731, pp. 145922-145922
Open Access | Times Cited: 55
Suvorexant for the treatment of insomnia
Laura H. Jacobson, Gabrielle E. Callander, Daniël Hoyer
Expert Review of Clinical Pharmacology (2014) Vol. 7, Iss. 6, pp. 711-730
Closed Access | Times Cited: 52
Direct Access to Multifunctionalized Norcamphor Scaffolds by Asymmetric Organocatalytic Diels–Alder Reactions
Rasmus Mose, Magnus E. Jensen, Gert Preegel, et al.
Angewandte Chemie International Edition (2015) Vol. 54, Iss. 46, pp. 13630-13634
Closed Access | Times Cited: 42
Effect of suvorexant on event-related oscillations and EEG sleep in rats exposed to chronic intermittent ethanol vapor and protracted withdrawal
Manuel Sánchez-Alavez, Jessica Benedict, Derek N. Wills, et al.
SLEEP (2019) Vol. 42, Iss. 4
Open Access | Times Cited: 22
Direct Access to Multifunctionalized Norcamphor Scaffolds by Asymmetric Organocatalytic Diels–Alder Reactions
Rasmus Mose, Magnus E. Jensen, Gert Preegel, et al.
Angewandte Chemie (2015) Vol. 127, Iss. 46, pp. 13834-13838
Closed Access | Times Cited: 19
Synthesis and characterization of a new Positron emission tomography probe for orexin 2 receptors neuroimaging
Ping Bai, Yan Liu, Yulong Xu, et al.
Bioorganic Chemistry (2022) Vol. 123, pp. 105779-105779
Open Access | Times Cited: 10
The Discovery of Suvorexant: Lessons Learned That Can Be Applied to Other CNS Drug Development Efforts
Jason M. Uslaner, W. Joseph Herring, Paul J. Coleman
ACS Pharmacology & Translational Science (2020) Vol. 3, Iss. 1, pp. 161-168
Open Access | Times Cited: 13
[3+2] Cycloaddition-based one-pot synthesis of 3,9-diazabicyclo[4.2.1]nonane-containing scaffold
Xiaofeng Zhang, Marc Legris, Alex Muthengi, et al.
Chemistry of Heterocyclic Compounds (2017) Vol. 53, Iss. 4, pp. 468-473
Closed Access | Times Cited: 14
Organocatalytic Mannich Reactions on a Carbapenem Core – Synthesis of Mannich Bases and Bicyclic Diazanonanes
Zamani E. D. Cele, Sachin A. Pawar, Tricia Naicker, et al.
European Journal of Organic Chemistry (2014) Vol. 2014, Iss. 11, pp. 2253-2260
Closed Access | Times Cited: 12
Toward the Scale-Up of a Bicyclic Homopiperazine via Schmidt Rearrangement and Photochemical Oxaziridine Rearrangement in Continuous-Flow
Michael Brown, Mohammed Aljarah, Hannah Asiki, et al.
Organic Process Research & Development (2020) Vol. 25, Iss. 1, pp. 148-156
Open Access | Times Cited: 7
Efficient unified synthesis of diverse bridged polycyclic scaffolds using a complexity-generating ‘stitching’ annulation approach
Stuart A. Rice, Daniel J. Cox, Stephen P. Marsden, et al.
Chemical Communications (2020) Vol. 57, Iss. 5, pp. 599-602
Open Access | Times Cited: 7
Remote Asymmetric Bisvinylogous [4+2] Cycloaddition Reaction to Synthesize Spirocyclic Frameworks
Raquel Hidalgo‐León, Nerea Alberro, Fernando P. Cossío, et al.
Advanced Synthesis & Catalysis (2023) Vol. 365, Iss. 19, pp. 3253-3259
Open Access | Times Cited: 2
Identification of Synthetic Activators of Cancer Cell Migration by Hybrid Deep Learning
Dominique Bruns, Erik Gawehn, Karthiga Santhana Kumar, et al.
ChemBioChem (2019) Vol. 21, Iss. 4, pp. 500-507
Closed Access | Times Cited: 3
Development of a Crystallization-Induced Diastereomer Transformation of Oxime Isomers for the Asymmetric Synthesis of (1S,6R)-3,9-Diazabicyclo[4.2.1]nonane
Vladislav G. Lisnyak, Yichen Tan, Antonio Ramı́rez, et al.
The Journal of Organic Chemistry (2023) Vol. 88, Iss. 17, pp. 12493-12501
Closed Access | Times Cited: 1
Orexin Receptor Antagonists
Brock T. Shireman, Michael A. Letavic
Elsevier eBooks (2016), pp. 225-279
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top